Galloway A C, Colvin S B, Grossi E A, Baumann F G, Sabban Y P, Esposito R, Ribakove G H, Culliford A T, Slater J N, Glassman E
Department of Surgery, New York University Medical Center, NY 10016.
Ann Thorac Surg. 1990 Jan;49(1):84-91; discussion 91-3. doi: 10.1016/0003-4975(90)90360-i.
A retrospective analysis of an institutional experience with aortic valve replacement (AVR) in patients 70 years of age or older during 1976 to 1987 was performed. The study was prompted in part by the current interest in palliative aortic valvoplasty, an interest based to a certain extent on the impression that AVR in the elderly has a high mortality. The mean age of the patients was 75.0 +/- 4.0 years (+/- the standard deviation) (range, 70 to 89 years). Eighty-three percent of patients received porcine valves and 17%, mechanical valves. Preoperatively 32% were in New York Heart Association class III, and 59% were in class IV. Operative mortality was 5.6% for elective isolated AVR for aortic stenosis (19% of all patients), 8.2% for all isolated AVR (38%), and 12.4% overall. Concomitant operative procedures were done in 62.0%; AVR with coronary artery bypass grafting (42%) had an operative mortality of 14.3%. Multivariate analysis showed significant predictors of operative mortality to be emergency operation (p less than 0.01), isolated aortic regurgitation (p = 0.01), and previous cardiac operation (p = 0.02). Follow-up (34 +/- 27 months) was 94% complete. Five-year survival from late cardiac-related death was 81.0%. The constant yearly hazard rate for late death for patients 70 years of age or older who underwent AVR was 5.42% per year, which is similar to the 5.77% per year rate calculated for age-matched and sex-matched controls. Five-year freedom from reoperation was 99%; from late thromboembolic complications, 91%; and from late anticoagulant-related complications, 94%. Freedom from all valve-related morbidity and mortality was 61% at 5 years.(ABSTRACT TRUNCATED AT 250 WORDS)
对1976年至1987年间70岁及以上患者进行主动脉瓣置换术(AVR)的机构经验进行了回顾性分析。这项研究部分是由当前对姑息性主动脉瓣成形术的兴趣所推动的,这种兴趣在一定程度上基于这样一种印象,即老年患者的AVR死亡率很高。患者的平均年龄为75.0±4.0岁(±标准差)(范围为70至89岁)。83%的患者接受了猪瓣膜,17%接受了机械瓣膜。术前,32%的患者为纽约心脏协会III级,59%为IV级。择期单纯主动脉瓣狭窄AVR的手术死亡率为5.6%(占所有患者的19%),所有单纯AVR的手术死亡率为8.2%(占38%),总体手术死亡率为12.4%。62.0%的患者进行了同期手术;主动脉瓣置换术联合冠状动脉搭桥术(42%)的手术死亡率为14.3%。多变量分析显示,手术死亡率的显著预测因素为急诊手术(p<0.01)、单纯主动脉瓣关闭不全(p = 0.01)和既往心脏手术(p = 0.02)。随访(34±27个月)的完成率为94%。因心脏相关晚期死亡的五年生存率为81.0%。接受AVR的70岁及以上患者晚期死亡的恒定年风险率为每年5.42%,这与年龄和性别匹配的对照组计算出的每年5.77%的风险率相似。五年免于再次手术率为99%;免于晚期血栓栓塞并发症率为91%;免于晚期抗凝相关并发症率为94%。五年免于所有瓣膜相关发病率和死亡率为61%。(摘要截断于250字)